Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
SPARC1613
Advanced Accelerator Applications
Recurrent or Metastatic Breast Cancer
1 trial -
SZ011 CAR-NK
The First People's Hospital of Lianyungang
Advanced Triple Negative Breast Cancer
1 trial -
TTI-101
Tvardi Therapeutics
Breast Cancer
2 trials -
Trastuzumab
Hoffmann-La Roche
Early Breast Cancer
1 trial -
Vantictumab combined with paclitaxel
Mereo BioPharma Group plc
Metastatic Breast Cancer
1 trial -
interleukin-4 PE38KDEL cytotoxin
NEUROCRINE BIOSCIENCES INC
Breast Cancer
1 trial -
limonene containing massage oil
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Abemaciclib
Eli Lilly and Company
Metastatic Breast Cancer
1 trial -
Dexmedetomidine
Peking University Third Hospital
Breast Cancer
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
OBU-BC-II-206
The First People's Hospital of Lianyungang
HER2 Positive Breast Cancer
1 trial -
Pegylated liposomal doxorubicin
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Ribociclib
Novartis Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
docetaxel
Hoffmann-La Roche
Breast Cancer
2 trials -
silk suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
89Zr-trastuzumab
United Therapeutics Europe Ltd
Breast Cancer Metastases
1 trial -
Accelerated partial breast irradiation
Universal Integrated
Breast Cancer
1 trial -
Albumin paclitaxel/neutrophil drug
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Biobran supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Stages I
1 trial -
Boost to the tumour bed
United Therapeutics Europe Ltd
Early Breast Cancer
1 trial -
Breast MRI interpretation
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.